[Resistance and serotype of 123 strains of Streptococcus pneumoniae]

Hong-Yu Ren1, Xiao-Lei Wang, Ma-Chao Li

  • 1State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Zhongguo Yi Miao He Mian Yi
|May 11, 2010
PubMed
Abstract

Insights

Antibiotic resistance in Streptococcus pneumoniae is a serious concern, with all tested strains resistant to azithromycin (AZM). Prevalent multi-resistant serotypes include 6 and 19, highlighting urgent public health implications.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Context:

  • Streptococcus pneumoniae is a leading cause of bacterial infections worldwide.
  • Antibiotic resistance poses a significant threat to effective treatment.
  • Understanding serotype distribution is crucial for vaccine development and public health strategies.

Purpose:

  • To determine the antibiotic resistance patterns of Streptococcus pneumoniae isolates.
  • To identify the prevalence of different serotypes among these isolates.
  • To investigate the association between serotype and antibiotic resistance.

Summary:

  • This study analyzed 123 strains of Streptococcus pneumoniae for antibiotic susceptibility and serotyping.
  • All strains exhibited resistance to azithromycin (AZM), with high resistance rates also observed for macrolides (MH) and trimethoprim-sulfamethoxazole (SXT).
  • Eleven serotypes were identified, with serogroups 6, 14, 15, 19, and 23 being most prevalent. Notably, serogroups 6 and 19 harbored the majority of multi-drug resistant strains.

Impact:

  • The findings underscore the critical issue of antibiotic resistance in Streptococcus pneumoniae.
  • The prevalence of multi-resistant strains, particularly within serogroups 6 and 19, necessitates targeted interventions.
  • This data is vital for informing clinical treatment guidelines and guiding the development of new antimicrobial strategies and vaccines.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...